CENT’s Q3 2026: Margin Strength Grows in Garden, While Pet Unit Reshapes Strategy with TRIXIE Pitch

Overview: a quarter of contrasts, guided by repositioning

The fiscal 2026 third quarter for Central Garden & Pet Company—trading as CENT on NASDAQ—delivered a classic portfolio story: the top line softened year over year, but margins and business focus ticked higher on several fronts. Net sales declined to $882 million from $961 million a year ago, driven in part by the exit of the pet distribution business earlier in the year. Yet organic net sales rose to $862 million, up 2% versus the prior-year figure. The firm used the revenue backdrop to showcase margin discipline and a brighter outlook for the ongoing year, including a strategic pivot toward Europe via a majority stake acquisition in TRIXIE, a leading European pet-products player.

On the earnings line, GAAP diluted EPS came in at $1.45, down from $1.52 a year earlier, while non‑GAAP EPS held at $1.54 versus $1.56. Adjusted EBITDA stood at $162 million, down modestly from $167 million, with margin expansion to 18.3% from 17.3%. The release notes the larger context of a more favorable margin mix, aided by the exit of the pet distribution business and a stronger contribution from the Garden segment.

Key Highlights

• Consolidated results: Net sales $882m; prior year $961m. Organic net sales +2% to $862m.
• Margins: Gross margin 35.9% (+130 bps); operating margin 14.3% (+20 bps). Non-GAAP operating margin 15.4% (+90 bps).
• Profitability: Net income $90m; GAAP EPS $1.45; non-GAAP EPS $1.54; prior-year EPS $1.52 (GAAP) and $1.56 (non-GAAP).
• Segment notes: Pet net sales $400m (down from $493m); Garden net sales $482m (up 3%).
• Guidance: Non-GAAP diluted EPS guidance raised to $2.85 or better for the fiscal year; no explicit revenue forecast was provided beyond the EPS outlook.
• Strategic move: Definitive agreement to acquire a majority interest in TRIXIE, expanding presence in Europe.

In short: the quarter reads as a rebalanced portfolio—revenue softness in the legacy pet-distribution business, but improving margins and a clearer path to Europe expansion via TRIXIE.

Pet Segment: Drag from a divestiture, lift from price and mix

The Pet segment delivered net sales of $400 million, down sharply from $493 million year-over-year, reflecting the exit from the pet distribution business. Organic net sales in the Pet segment were $380 million, up 2% despite the overall headwind from the exit. Operating income fell to $67 million from $76 million, though margins improved to 16.7% from 15.5%, helped by a leaner cost structure and mix shift. Non-GAAP operating income was $76 million, with margin improving to 19.0% from 15.8%.

Adjusted EBITDA for the Pet segment stood at $86 million, versus $88 million previously, with margins around 21.4% versus 17.9% in the prior period—a telling hint that the business is reaping benefit from operating discipline even as the top line recalibrates.

Note: the pet-distribution exit is explicitly cited as a primary driver behind the topline decline, underscoring management’s willingness to “trim the weeds” to focus on higher‑return categories.

Garden Segment: Growth driven by core categories

The Garden segment posted net sales of $482 million, up from $468 million—a 3% rise. Management attributes the gain to strength across Wild Bird, Fertilizer and Controls, and Grass Seeds. The growth in Garden contrasts with the Pet weakness, illustrating the company’s strategic tilt toward its higher-margin, more stable categories that complement retail channels and seasonal demand cycles.

Outlook and implications: Europe on the horizon, EPS focus intact

The company raised its outlook for fiscal 2026 non-GAAP diluted EPS to $2.85 or better, up from $2.70 or better. This adjustment signals confidence that the margin restoration and segment mix improvements can offset near-term top-line softness, particularly in the Pet segment.

From an investor-relations perspective, the TRIXIE minority-stake move adds a tangible growth vector in Europe, potentially lifting the company’s multi-region narrative and diversifying revenue exposure away from a pet-distribution exit that created near-term revenue headwinds.

On the earnings front, the year‑to‑date narrative remains mixed: GAAP EPS declined versus the prior year, driven by the revenue step-down, while non-GAAP results and EBITDA margins show resilience. For market peers in the pet and garden space, CENT’s strategy underlines two familiar themes: (1) portfolio optimization via selective divestitures and targeted acquisitions, and (2) a pivot to higher‑margin categories that can sustain earnings quality even when reported revenue slips.

What this portends for CENT and peers

In a sector where growth often rides a mix of consumer demand and product assortment, CENT’s quadrant: margin discipline and strategic repositioning, with Europe expansion, offers a clear path. The pet-distribution exit reduces exposure to lower-margin territories, while the Garden business acts as a steadier cash generator. The TRIXIE deal is the marquee move—if integration proceeds smoothly, CENT could see a longer runway of higher-margin sales in Europe and stronger branding in pet accessories and snacks.

As for EPS trajectory, the shift from GAAP to non-GAAP earnings illustrates how management is framing profitability independent of one-off or restructuring effects. If analysts’ EPS consensus nudges higher on TRIXIE-driven growth and margin normalization, the stock could receive a more constructive read despite headline revenue softness. The absence of a blunt revenue forecast beyond the EPS guidance leaves room for interpretation, making the stock more sensitive to quarterly cadence and the pace of TRIXIE integration.

Looking ahead, peers with diversified product pipelines and international ambitions may view this quarter as a blueprint: yes, you can rebalance with a portfolio pivot, but you must ensure execution on the new growth engines. CENT’s experience suggests that if the European expansion lands with a manageable integration risk and margin upside, the broader garden-pet complex could see a multi-quarter lift in profitability, even if the near-term revenue line remains lumpy.

Closing thoughts

Central Garden & Pet’s Q3 2026 results remind investors that earnings quality can outlive headline revenue weakness. The company’s discipline on costs, the shift toward higher-margin categories, and Europe-focused expansion through TRIXIE provide a coherent narrative for the rest of fiscal 2026 and into 2027. For CENT, the test is simple: translate margin gains into sustainable earnings growth and confirm that the Europe bet compounds efficiently with the Garden business domestically. If that path holds, the quarters ahead may well sprout into a steadier garden of returns for shareholders.